ZA200704926B - Modified human growth hormone - Google Patents
Modified human growth hormoneInfo
- Publication number
- ZA200704926B ZA200704926B ZA200704926A ZA200704926A ZA200704926B ZA 200704926 B ZA200704926 B ZA 200704926B ZA 200704926 A ZA200704926 A ZA 200704926A ZA 200704926 A ZA200704926 A ZA 200704926A ZA 200704926 B ZA200704926 B ZA 200704926B
- Authority
- ZA
- South Africa
- Prior art keywords
- growth hormone
- human growth
- modified human
- modified
- hormone
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH] (Somatotropin)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/61—Growth hormones [GH] (Somatotropin)
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
- C08G65/329—Polymers modified by chemical after-treatment with organic compounds
- C08G65/333—Polymers modified by chemical after-treatment with organic compounds containing nitrogen
- C08G65/33396—Polymers modified by chemical after-treatment with organic compounds containing nitrogen having oxygen in addition to nitrogen
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6875—Nucleoproteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US63861604P | 2004-12-22 | 2004-12-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200704926B true ZA200704926B (en) | 2008-12-31 |
Family
ID=38943761
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200704924A ZA200704924B (en) | 2004-12-22 | 2005-12-21 | Methods for expression and purification of recombinant human growth hormone |
ZA200704928A ZA200704928B (en) | 2004-12-22 | 2005-12-21 | Formulations of human growth hormone comprising a non-naturally encoded amino acid |
ZA200704926A ZA200704926B (en) | 2004-12-22 | 2005-12-21 | Modified human growth hormone |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200704924A ZA200704924B (en) | 2004-12-22 | 2005-12-21 | Methods for expression and purification of recombinant human growth hormone |
ZA200704928A ZA200704928B (en) | 2004-12-22 | 2005-12-21 | Formulations of human growth hormone comprising a non-naturally encoded amino acid |
Country Status (2)
Country | Link |
---|---|
CN (3) | CN101090980A (en) |
ZA (3) | ZA200704924B (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ600363A (en) * | 2009-12-21 | 2014-07-25 | Ambrx Inc | Modified porcine somatotropin polypeptides and their uses |
CN102062776A (en) * | 2010-12-16 | 2011-05-18 | 中华人民共和国天津出入境检验检疫局 | Babesia caballi disease immunoblotting detection method and preparation of kit |
CN102838671B (en) * | 2011-06-23 | 2014-06-11 | 北京大学 | Growth hormone with site-specific mutagenesis and site-specific decoration, preparation method and applications of growth hormone |
EP2820033A1 (en) * | 2012-02-29 | 2015-01-07 | Ambrx, Inc. | Interleukin-10 polypeptide conjugates and their uses |
GB201303876D0 (en) * | 2013-01-29 | 2013-04-17 | Verenium Corp | Animal feed enzyme extraction |
JP7441826B2 (en) * | 2018-09-11 | 2024-03-01 | アンブルックス,インコーポレイテッド | Interleukin-2 polypeptide conjugates and uses thereof |
KR20240024235A (en) * | 2021-07-29 | 2024-02-23 | 노보코덱스 바이오파마슈티컬즈 컴퍼니 리미티드 | Non-natural amino acids and uses thereof, recombinant proteins containing them, and recombinant protein conjugates |
CN113698468B (en) * | 2021-09-01 | 2022-10-11 | 浙江新码生物医药有限公司 | Human interleukin 2-polyethylene glycol conjugate and application thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020077461A1 (en) * | 1996-04-24 | 2002-06-20 | Soren Bjorn | Pharmaceutical formulation |
BRPI0507169A (en) * | 2004-02-02 | 2007-06-26 | Ambrx Inc | modified human growth hormone polypeptides and their uses |
-
2005
- 2005-12-21 CN CNA2005800444641A patent/CN101090980A/en active Pending
- 2005-12-21 ZA ZA200704924A patent/ZA200704924B/en unknown
- 2005-12-21 ZA ZA200704928A patent/ZA200704928B/en unknown
- 2005-12-21 CN CN2005800444355A patent/CN101374536B/en not_active Expired - Fee Related
- 2005-12-21 ZA ZA200704926A patent/ZA200704926B/en unknown
- 2005-12-21 CN CNA2005800444637A patent/CN101356269A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
ZA200704928B (en) | 2009-04-29 |
ZA200704924B (en) | 2009-04-29 |
CN101374536B (en) | 2013-09-25 |
CN101374536A (en) | 2009-02-25 |
CN101356269A (en) | 2009-01-28 |
CN101090980A (en) | 2007-12-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL182915A0 (en) | Inter-facet implant | |
GB0411360D0 (en) | Implant | |
ZA200703851B (en) | Intervertébral implant | |
EG24919A (en) | Agricultural-chemical preparation having controlled releaseability | |
GB0417078D0 (en) | Flexible implant | |
GB0400571D0 (en) | Implant | |
EP1814499A4 (en) | Artificial hand | |
EP1799134A4 (en) | Implant device | |
PL1671529T3 (en) | Combine harvester | |
EP1734904A4 (en) | Cement-directing orthopedic implants | |
EP1827490A4 (en) | Implantable device | |
HK1114343A1 (en) | Implant back-injecting device | |
HK1075423A1 (en) | Human nosecock | |
GB0426841D0 (en) | Medical implant | |
EP1919492A4 (en) | Growth hormone secretagogues | |
EP1760098A4 (en) | Biocompatible material | |
ZA200704926B (en) | Modified human growth hormone | |
EP1806105A4 (en) | Medical wire | |
ZA200606224B (en) | Modified human growth hormone polypeptides and their uses | |
EP1812794A4 (en) | Autocrine growth factor receptors and methods | |
GB0406822D0 (en) | Surgical fastening | |
GB2411839B (en) | Prosthesis | |
GB0423415D0 (en) | Prosthesis | |
EP1806104A4 (en) | Medical wire | |
IL180425A0 (en) | Hair growth promoting agents |